Cell Therapy in the Heart: Cell Production, Transplantation, and Applications
| Abstract |
|
|
Cardiac dysfunction resulting from various insults to the myocardium can ultimately lead to the development of heart failure.
Owing to the limited regenerative capacity of adult cardiac tissue and the lack of a resident cardiac progenitor cell equivalent
to the skeletal myoblast, the transplantation of myogenic cells into the myocardium has been investigated as a novel mechanism
to repair damaged and dysfunctional myocardium. For maximal impact on cardiac function, the design of cellular therapies must
carefully consider the identity of the transplanted cells as well as the method of cell delivery. This review details techniques
for the purification of commonly investigated cell grafts, including skeletal myoblasts and mesenchymal stem cells, and the
methods to deliver these grafts to the myocardium of laboratory animals.
Affiliation(s): (3) Departments of Pediatrics and Molecular Genetics and Microbiology, University of Florida School of Medicine, Gainesville, FL
(4) Division of Cardiology, Peter Belfer Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD
(5) Osiris Therapeutics Inc., Baltimore, MD
(6) Peter Belfer Laboratory, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD
(4) Division of Cardiology, Peter Belfer Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD
(5) Osiris Therapeutics Inc., Baltimore, MD
(6) Peter Belfer Laboratory, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD
Series: Methods in Molecular Biology | Volume: 219 | Pub. Date: Dec-19-2002 | Page Range: 73-81 | DOI: 10.1385/1-59259-350-X:73
Subject: Genetics/Genomics
Comments (Loading...) |
||
Loading... |





















